Quantum Biopharma (QNTM) Other Non Operating Income (2019 - 2026)
Quantum Biopharma (QNTM) reported Other Non Operating Income of $35802.0 for Q1 2026, up 119.34% on a YoY basis from $16322.7 in Q1 2025, and up 418.24% sequentially from -$11250.0 in Q3 2025.
Quantum Biopharma (QNTM) Other Non Operating Income (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Other Non Operating Income data on file, last reported at $35802.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 119.34% year-over-year to $35802.0; the trailing twelve-month figure through Mar 2026 stood at -$50311.0 (up 63.99% YoY), and the FY2024 full-year result was $57743.0, changed N/A from the prior year.
- Other Non Operating Income climbed to $35802.0 in Q1 2026, from -$11250.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $206950.0 in Q1 2023 to a low of -$242519.0 in Q1 2022.
- A 5-year average of -$6012.0 and a median of $3113.0 in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income surged 185.33% in 2023 and slumped 1159.34% in 2025, its largest moves.
- Tracing QNTM's Other Non Operating Income over 5 years: stood at -$37139.0 in 2022, then surged by 657.23% to $206950.0 in 2023, then slumped by 72.1% to $57743.0 in 2024, then plunged by 119.48% to -$11250.0 in 2025, then jumped by 418.24% to $35802.0 in 2026.
- Business Quant data shows QNTM's Other Non Operating Income at $35802.0 in Q1 2026, -$11250.0 in Q3 2025, and $110267.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,802.00 |
| Sep 30, 2025 | -11,250.00 |
| Jun 30, 2025 | 110,267.00 |
| Mar 31, 2025 | -185,130.00 |
| Dec 31, 2024 | 57,743.00 |
| Sep 30, 2024 | -12,320.00 |
| Mar 31, 2024 | 17,476.00 |
| Mar 31, 2023 | 206,950.00 |
| Sep 30, 2022 | -37,139.00 |
| Mar 31, 2022 | -242,519.00 |
| Jun 30, 2021 | 3.02 Mn |
| Sep 30, 2020 | 5.16 Mn |
| Jun 30, 2020 | 262,575.93 |
| Mar 31, 2020 | 1.72 Mn |
| Sep 30, 2019 | 5.15 Mn |
| Jun 30, 2019 | 1.31 Mn |
| Mar 31, 2019 | 227,730.84 |